Targeting tyrosine kinases and autophagy in prostate cancer.
about
Antibody Microarray Analysis of Signaling Networks Regulated by Cxcl13 and Cxcr5 in Prostate CancerDifferential requirement for Src family tyrosine kinases in the initiation, progression, and metastasis of prostate cancerTargeting autophagy overcomes Enzalutamide resistance in castration-resistant prostate cancer cells and improves therapeutic response in a xenograft modelCSF1 receptor targeting in prostate cancer reverses macrophage-mediated resistance to androgen blockade therapy.miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.Autophagy as a modulator and target in prostate cancer.Celastrol Induces Autophagy by Targeting AR/miR-101 in Prostate Cancer Cells.Progenitor/stem cell transplantation for repair of myocardial infarction: Hype or hope?AMBRA1 and SQSTM1 expression pattern in prostate cancer.Androgen receptor (AR) positive vs negative roles in prostate cancer cell deaths including apoptosis, anoikis, entosis, necrosis and autophagic cell death.Autophagy in prostate cancer and androgen suppression therapy.Sorafenib-induced defective autophagy promotes cell death by necroptosis.Personalized prostate cancer therapy based on systems analysis of the apoptosis regulatory network.Autophagy activated by the c-Jun N-terminal kinase-mediated pathway protects human prostate cancer PC3 cells from celecoxib-induced apoptosisPhosphotyrosine enrichment identifies focal adhesion kinase and other tyrosine kinases for targeting in canine hemangiosarcoma.Negative LC3b immunoreactivity in cancer cells is an independent prognostic predictor of prostate cancer specific death.
P2860
Q28388072-A9B76312-894E-4AC3-953A-0D8C60FCAFD7Q34364815-E0AE14D2-4DB3-4B04-95AF-878D02C983B5Q34411761-44600427-5D91-41BA-A992-1EC133AD12F9Q35178381-4276A0CF-854F-4751-B594-0DA5DDACBD8BQ35207623-52E9C2E6-C00A-4C9D-9388-97F80389653BQ35557084-E458E91B-5579-44E5-B770-F9874F2DBC90Q35810293-2C31ED3A-DFF7-4357-A1B9-98F8A2BB00C9Q36108608-4B83D609-4DF7-4C39-AC15-1EF0E9AC6442Q36149486-94BD7C8F-6F1A-4970-B059-97CD8BFD3D10Q37322621-ACD0CC21-2F51-44E6-8B5E-6B586AFF5EE5Q38112596-0AA737A8-FFEB-4B19-8D60-1E4DA4FFFF1AQ38261907-9D232B34-B0C4-4D52-B514-52690EEE1B10Q38314425-D4F1C52D-4623-4C53-84D5-8D97D740CB27Q38701724-96E5EC47-D5C4-4E1C-95F8-D86AF207F333Q39367500-3ABCDBF8-FF53-4C7A-A3DE-E6C74ECF82E6Q42223195-70679DA4-2313-4B23-8DCB-64BB7DA81378
P2860
Targeting tyrosine kinases and autophagy in prostate cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 02 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeting tyrosine kinases and autophagy in prostate cancer.
@en
Targeting tyrosine kinases and autophagy in prostate cancer.
@nl
type
label
Targeting tyrosine kinases and autophagy in prostate cancer.
@en
Targeting tyrosine kinases and autophagy in prostate cancer.
@nl
prefLabel
Targeting tyrosine kinases and autophagy in prostate cancer.
@en
Targeting tyrosine kinases and autophagy in prostate cancer.
@nl
P2860
P921
P1433
P1476
Targeting tyrosine kinases and autophagy in prostate cancer.
@en
P2093
Hsing-Jien Kung
P2860
P2888
P356
10.1007/S12672-010-0053-3
P577
2010-12-02T00:00:00Z
2011-02-01T00:00:00Z